Markets
MYL

This Week's Top Value Stocks: (PFE) (MYL)

Looking for the best value stocks? Tracey Ryniec, Stock Strategist at Zacks Investment Research, discusses two stocks that might be worth a closer look by value investors: Pfizer (PFE) and Mylan NV (MYL).

Both companies have forward P/Es well below the average of the S&P 500, which is now a sky-high level of 18. They also are in favor with analysts, as 2015 and 2016 earnings estimates have been moving higher.

They both have been returning value to shareholders. Pfizer is expected to continue to pay its juicy dividend, even after its merger with Allergan. Mylan recently announced a $1 billion share buyback program.

But what else should investors take away from these two companies? Watch our short video below to learn more about these value stocks!

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

PFIZER INC (PFE): Free Stock Analysis Report

MYLAN NV (MYL): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

MYL PFE

Other Topics

Stocks

Latest Markets Videos

    Zacks

    Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

    Learn More